Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program
- 1 December 1987
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 48 (6) , 964-968
- https://doi.org/10.1016/s0015-0282(16)59592-2
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Differences in ovarian stimulation in human menopausal gonadotropin treated woman may be related to follicle-stimulating hormone accumulationFertility and Sterility, 1986
- A new approach to follicular stimulation for in vitro fertilization: programed oocyte retrievalFertility and Sterility, 1986
- Follicular maturation parameters associated with the failure of oocyte retrieval, fertilization, and cleavage in vitroFertility and Sterility, 1986
- The use of high-dose human menopausal gonadotropin in an in vitro fertilization programFertility and Sterility, 1983
- The importance of the follicular phase to success and failure in in vitro fertilizationFertility and Sterility, 1983
- Human gonadotropin therapy. I. Serum estradiol and progesterone patterns during conceptual cyclesFertility and Sterility, 1983
- Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: Phase I, 1981Fertility and Sterility, 1983
- Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: Phase II, 1981Fertility and Sterility, 1983
- ESTABLISHING FULL‐TERM HUMAN PREGNANCIES USING CLEAVING EMBRYOS GROWN IN VITRO*BJOG: An International Journal of Obstetrics and Gynaecology, 1980